Preventive Treatment of Migraine-Reference-Cited by-同舟云学术

Preventive Treatment of Migraine

Published:2022-08 Issue:04 Volume:42 Page:503-511
ISSN:0271-8235
Container-title:Seminars in Neurology
language:en
Short-container-title:Semin Neurol

Author:

Todd Candice M.¹^ORCID,Sandoe Claire H.¹,Lay Christine¹

Affiliation:

1. Department of Neurology, Centre for Headache, Women's College Hospital, University of Toronto, Toronto, Canada

Abstract

AbstractMigraine significantly impacts individuals from all walks of life and from all around the globe. Chronic or high-frequency episodic migraine has similar disability and burden on the healthcare system and can be challenging to manage. The focus of this article is to provide an outline of the available pharmacological and nonpharmacological evidence-based strategies that clinicians can employ to build a “toolbox” for their patients.

Publisher

Georg Thieme Verlag KG

Subject

Neurology (clinical),Neurology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1933-4366.pdf

Reference82 articles.

1. Epidemiology of headache;B K Rasmussen;Cephalalgia,2001

2. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study;D W Dodick;Headache,2016

3. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study;D C Buse;Headache,2020

4. A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: demographics and headache-related disability;R B Lipton;Headache,2016

5. Chronic versus episodic migraine: the 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency;R Ishii;Headache,2021